---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-24-000311"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-04T00:09:19.553418+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences SPAC gets $1.2M sponsor note, extends deadline to May 14

## Summary
- Issued $1.2M promissory note to sponsor, unsecured, no interest, due by Dec 31, 2024 or upon business combination.
- Sponsor deposited $60,000 into trust to extend business combination deadline from April 15 to May 14, 2024.
- Principal forgiven if no business combination occurs by charter deadline; sponsor waives trust account claims.

## SEC filing metadata
- accession: 0000898432-24-000311
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000311/0000898432-24-000311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000311/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-24-000311
- JSON: https://secwatch.observer/filing/0000898432-24-000311.json
- Plain text: https://secwatch.observer/filing/0000898432-24-000311.txt

## Key facts
- Debt Financings
  OSR Holdings, Inc. incurred loan of $1,200,000 with Bellevue Global Life Sciences Investors, LLC at not interest bearing maturing earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial business combination.
  - Instrument: loan
  - Principal: $1,200,000
  - Counterparty: Bellevue Global Life Sciences Investors, LLC
  - Rate: not interest bearing
  - Maturity: earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial business combination
  - Event: incurrence
  source text: On April 8, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $1,200,000 to Bellevue Global Life Sciences Investors, LLC (“ BGLSI ”), the sponsor of the Company. The Promissory Note is not interest bearing and is payable in full on the earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial business combination (the “ Maturity Date ” ) .
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000311/0000898432-24-000311-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.